Related Experiment Videos
Studies on Marek's disease lymphoma-derived cell lines
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Coronary vascular morphology in pressure-overload left ventricular hypertrophy.
Journal of molecular and cellular cardiology·1996
Aberrant expression of Ia-like antigens on tumor cells of regressing but not of progressing Rous sarcomas.
European journal of immunology·1987
Immune mechanisms in infections of poultry.
Veterinary immunology and immunopathology·1987
Isolation of very virulent pathotypes of Marek's disease virus from vaccinated chickens in Europe.
The Veterinary record·1986
The differential contribution of B and T lymphocytes to susceptibility to Marek's disease in RPL line-7 chickens.
Avian pathology : journal of the W.V.P.A·1986
The expression of Marek's disease tumour-associated surface antigen in various avian species.
Avian pathology : journal of the W.V.P.A·1984
Entrapment of L-asparaginase in red blood cells. A strategy to improve treatment of acute lymphoblastic leukemia.
Bibliotheca haematologica·1985
G6PD encapsulation and metabolic properties of loaded erythrocytes.
Bibliotheca haematologica·1985
Entrapment of normal and mutant glucose 6-phosphate dehydrogenase (G6PD) within G6PD deficient erythrocytes.
Bibliotheca haematologica·1985
Membrane phospholipid asymmetry and the adherence of loaded red blood cells.
Bibliotheca haematologica·1985
Quantitative mitral regurgitation and conventional echocardiographic variables in canine myxomatous mitral valve disease.
Frontiers in veterinary science·2026
Prevalence of rs850683722 Variant and Its Influence on the Course of Myxomatous Mitral Valve Disease in 105 Cavalier King Charles Spaniel Dogs in the Polish Population.
Animals : an open access journal from MDPI·2026
Mammary neuroendocrine tumor in a mare.
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·2026